Healthcare -
Biotechnology - NASDAQ - US
$ 24.05
-4.37 %
$ 2.99 B
Market Cap
-15.03
P/E
APLS - TOTAL EQUITY
Total Equity APLS - Apellis Pharmaceuticals, Inc.
195 M
LAST VALUE
-1.05%
2 YEAR CAGR
3.86%
5 YEAR CAGR
45.67%
10 YEAR CAGR